Epilepsy drug derived from marijuana nears FDA approval …


cannabisShutterstock

An experimental drug derived from cannabis to treat epilepsy is
on the brink of becoming the first of its kind to win US
government approval.

The drug’s active ingredient is cannabidiol, the compound in
marijuana thought to be
responsible for many of its therapeutic
effects
. Cannabidiol doesn’t contain THC,
marijuana’s main psychoactive ingredient, so it doesn’t get
users high.

According to results from two large clinical trials
released over the past two months, however, cannabidiol does
appear
 to help reduce seizures in two of the
hardest-to-treat forms of epilepsy,
Lennox-Gastaut Syndrome
and Dravet
Syndrome
.

... read more at: http://www.businessinsider.com/marijuana-epilepsy-drug-2017-5

Leave a Reply

Your email address will not be published. Required fields are marked *